Revvity Inc
RVTY88.230USD
+0.330+0.38%
Close 08/01, 16:00（ET）Quotes delayed by 15 min
10.40BMarket Cap
36.29P/E TTM
More Details of Revvity Inc Company
Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Company Info
Ticker SymbolRVTY
Company nameRevvity Inc
IPO dateJul 06, 1965
Founded at1947
CEODr. Prahlad R. Singh, Ph.D.
Number of employees11000
Security typeOrdinary Share
Fiscal year-endJul 06
Address77 4Th Avenue
CityWALTHAM
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code02451
Phone17816636900
Websitehttps://www.revvity.com/
Ticker SymbolRVTY
IPO dateJul 06, 1965
Founded at1947
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.26K
+17.81%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
45.44K
+6.67%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
26.01K
+10.22%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
23.36K
+628.47%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
22.63K
+137.66%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
14.29K
+61.74%
Ms. Pascale Witz
Ms. Pascale Witz
Independent Director
Independent Director
13.71K
+21.36%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Independent Director
Independent Director
5.09K
+90.13%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
5.09K
+90.13%
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.26K
+17.81%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
45.44K
+6.67%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
26.01K
+10.22%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
23.36K
+628.47%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
22.63K
+137.66%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Product
562.68M
84.64%
Service
102.08M
15.36%
By RegionUSD
Name
Revenue
Proportion
Americas
304.63M
45.83%
Europe
181.79M
27.35%
Asia
178.34M
26.83%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Product
562.68M
84.64%
Service
102.08M
15.36%
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
T. Rowe Price Investment Management, Inc.
19.10%
The Vanguard Group, Inc.
12.16%
T. Rowe Price Associates, Inc.
7.96%
BlackRock Institutional Trust Company, N.A.
5.15%
Janus Henderson Investors
5.09%
Other
50.54%
Shareholders
Shareholders
Proportion
T. Rowe Price Investment Management, Inc.
19.10%
The Vanguard Group, Inc.
12.16%
T. Rowe Price Associates, Inc.
7.96%
BlackRock Institutional Trust Company, N.A.
5.15%
Janus Henderson Investors
5.09%
Other
50.54%
Shareholder Types
Shareholders
Proportion
Investment Advisor
69.85%
Investment Advisor/Hedge Fund
21.16%
Hedge Fund
2.47%
Pension Fund
1.65%
Research Firm
1.35%
Bank and Trust
1.33%
Sovereign Wealth Fund
1.02%
Individual Investor
0.32%
Family Office
0.05%
Other
0.79%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
1195
116.79M
99.09%
-3.51M
2025Q1
1255
117.73M
99.83%
-3.82M
2024Q4
1277
114.54M
95.28%
-3.97M
2024Q3
1253
112.35M
91.11%
-5.77M
2024Q2
1249
112.44M
91.13%
-1.63M
2024Q1
1287
107.57M
87.09%
-8.24M
2023Q4
1315
109.29M
88.55%
-2.41M
2023Q3
1347
106.10M
85.47%
-6.10M
2023Q2
1383
106.88M
85.21%
-9.65M
2023Q1
1406
108.31M
85.69%
-5.19M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
T. Rowe Price Investment Management, Inc.
22.52M
19.1%
+1.75M
+8.45%
Mar 31, 2025
The Vanguard Group, Inc.
14.33M
12.16%
+92.07K
+0.65%
Mar 31, 2025
T. Rowe Price Associates, Inc.
9.39M
7.96%
+1.93M
+25.90%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
6.07M
5.15%
+59.41K
+0.99%
Mar 31, 2025
Janus Henderson Investors
5.99M
5.09%
-364.31K
-5.73%
Mar 31, 2025
EdgePoint Investment Group Inc.
5.36M
4.55%
+1.30M
+32.10%
Mar 31, 2025
State Street Global Advisors (US)
5.17M
4.38%
+1.66K
+0.03%
Mar 31, 2025
Mitsubishi UFJ Asset Management Co., Ltd.
3.44M
2.92%
+62.31K
+1.84%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.99M
2.54%
+92.26K
+3.18%
Mar 31, 2025
Capital Research Global Investors
2.84M
2.41%
-152.06K
-5.09%
Mar 31, 2025
View more
Related ETFs
Updated: 7 hours ago
Updated: 7 hours ago
Name
Proportion
Otter Creek Focus Strategy ETF
2.35%
First Trust Indxx Medical Devices ETF
1.89%
T Rowe Price Capital Appreciation Equity ETF
1.69%
Invesco S&P 500 Equal Weight Health Care ETF
1.67%
VanEck Morningstar SMID Moat ETF
1.23%
ROBO Global Healthcare Technology & Innovation ETF
1.09%
Simplify Health Care ETF
1.07%
Pacer US Export Leaders ETF
0.98%
Janus Henderson US Sustainable Equity ETF
0.88%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.85%
View more
Otter Creek Focus Strategy ETF
Proportion2.35%
First Trust Indxx Medical Devices ETF
Proportion1.89%
T Rowe Price Capital Appreciation Equity ETF
Proportion1.69%
Invesco S&P 500 Equal Weight Health Care ETF
Proportion1.67%
VanEck Morningstar SMID Moat ETF
Proportion1.23%
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.09%
Simplify Health Care ETF
Proportion1.07%
Pacer US Export Leaders ETF
Proportion0.98%
Janus Henderson US Sustainable Equity ETF
Proportion0.88%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
Proportion0.85%
Dividend
A total of
168.35M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Oct 24, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 07, 2025 going ex on Jan 17, 2025
Jan 17, 2025
Feb 07, 2025
Jan 17, 2025
Jul 25, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 08, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 08, 2024
Oct 18, 2024
Apr 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 09, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 09, 2024
Jul 19, 2024
Jan 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 10, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 10, 2024
Apr 18, 2024
Oct 26, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 09, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Feb 09, 2024
Jan 18, 2024
Jul 21, 2023
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 10, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 10, 2023
Oct 19, 2023
Apr 25, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 11, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 11, 2023
Jul 20, 2023
Jan 26, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 12, 2023 going ex on Apr 20, 2023
Apr 21, 2023
May 12, 2023
Apr 20, 2023
Oct 27, 2022
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 10, 2023 going ex on Jan 19, 2023
Jan 20, 2023
Feb 10, 2023
Jan 19, 2023
Jul 22, 2022
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 11, 2022 going ex on Oct 20, 2022
Oct 21, 2022
Nov 11, 2022
Oct 20, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
